Immatics (IMTX) Inventory Average (2023 - 2025)
Immatics recorded quarterly Inventory Average of $527.6 million in Q3 2025, down 6.18% quarter-over-quarter from $562.3 million in Q2 2025, and up 1125.36% year-over-year from $43.1 million in Q3 2024.
Immatics' Inventory Average history runs 3 years deep, the most recent figure standing at $527.6 million for Q3 2025.
- In Q3 2025, Inventory Average rose 1125.36% year-over-year to $527.6 million; the TTM figure through Sep 2025 stood at $527.6 million (up 1125.36% YoY), while the FY2024 annual figure was $560.5 million, changed N/A from the prior year.
- Inventory Average came in at $527.6 million for Q3 2025 at Immatics, down from $562.3 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $616.4 million in Q1 2025 to a low of -$51.5 million in Q3 2024.
- A 3-year average of $302.5 million and a median of $309.6 million in 2024 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average fell 15.59% in 2024 and jumped 1125.36% in 2025, its largest moves.
- Immatics' Inventory Average stood at $197.6 million in 2023, then surged by 56.7% to $309.6 million in 2024, then soared by 70.41% to $527.6 million in 2025.
- According to Business Quant data, Inventory Average over the past three periods registered $527.6 million, $562.3 million, and $616.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 527.61 Mn |
| Jun 30, 2025 | 562.34 Mn |
| Mar 31, 2025 | 616.40 Mn |
| Dec 31, 2024 | 309.61 Mn |
| Sep 30, 2024 | -51.46 Mn |
| Dec 31, 2023 | 197.58 Mn |
| Sep 30, 2023 | -44.51 Mn |